Actavis Saves Allergan from Valeant Hostile Takeover with $66 Billion Deal, But Will Slash R&D

The seven-month battle over American Botox haven pharmaceutical company Allergan is over, after it accepted a friendly takeover bid from Irish integrated specialty pharmaceutical Actavis. The Actavis offer More...